Longer Omalizumab Use Eases Itch From Chronic Hives

The quality of life of patients with idiopathic urticaria improved when they stayed on the monoclonal antibody for 48 instead of 24 weeks, the XTEND-CIU study shows.
Medscape Medical News

http://ift.tt/2D2lvaN